BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8144000)

  • 1. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease.
    Reubi JC; Mazzucchelli L; Laissue JA
    Gastroenterology; 1994 Apr; 106(4):951-9. PubMed ID: 8144000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors.
    Mantyh CR; Vigna SR; Maggio JE; Mantyh PW; Bollinger RR; Pappas TN
    Neurosci Lett; 1994 Sep; 178(2):255-9. PubMed ID: 7529913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.
    Tavano F; Palmieri O; di Mola FF; Latiano A; Burbaci FP; Valvano MR; Corritore G; Augello B; Merla G; Annese V; Andriulli A; di Sebastiano P
    Dig Liver Dis; 2013 Dec; 45(12):1003-10. PubMed ID: 23827863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis.
    Mantyh CR; Vigna SR; Bollinger RR; Mantyh PW; Maggio JE; Pappas TN
    Gastroenterology; 1995 Sep; 109(3):850-60. PubMed ID: 7657114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease.
    Mantyh PW; Catton M; Maggio JE; Vigna SR
    Adv Exp Med Biol; 1991; 298():253-83. PubMed ID: 1659149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptors in human prostate and prostate cancer.
    Reubi JC; Waser B; Schaer JC; Markwalder R
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2806-14. PubMed ID: 7673428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin in the idiopathic inflammatory bowel diseases.
    Koch TR; Carney JA; Morris VA; Go VL
    Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.
    Renzi D; Pellegrini B; Tonelli F; Surrenti C; Calabrò A
    Am J Pathol; 2000 Nov; 157(5):1511-22. PubMed ID: 11073811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
    ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
    J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.
    Reubi JC; Mazzucchelli L; Hennig I; Laissue JA
    Gastroenterology; 1996 Jun; 110(6):1719-26. PubMed ID: 8964396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S; Seuwen K; Hoyer D
    Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons.
    Mantyh PW; Catton MD; Boehmer CG; Welton ML; Passaro EP; Maggio JE; Vigna SR
    Peptides; 1989; 10(3):627-45. PubMed ID: 2550912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent lack of somatostatin receptors in gastric mucosa of healing ulcers in rats.
    Reubi JC; Waser B; Schmassmann A; Halter F
    Gastroenterology; 1994 Aug; 107(2):339-46. PubMed ID: 8039610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory peptide receptors in human hepatocellular carcinomas.
    Reubi JC; Zimmermann A; Jonas S; Waser B; Neuhaus P; Läderach U; Wiedenmann B
    Gut; 1999 Nov; 45(5):766-74. PubMed ID: 10517918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
    Reubi JC; Waser B; Laissue JA; Gebbers JO
    Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
    Ter Beek WP; Muller ES; van den Berg M; Meijer MJ; Biemond I; Lamers CB
    Inflamm Bowel Dis; 2008 May; 14(5):612-9. PubMed ID: 18183601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.